Mental Health — The Effectiveness of 3DVR Horticultural Therapy on Older Adults
Citation(s)
Bossen A The importance of getting back to nature for people with dementia. J Gerontol Nurs. 2010 Feb;36(2):17-22. doi: 10.3928/00989134-20100111-01. Epub 2010 Feb 5. Review.
Chen YM, Ji JY Effects of Horticultural Therapy on Psychosocial Health in Older Nursing Home Residents: A Preliminary Study. J Nurs Res. 2015 Sep;23(3):167-71. doi: 10.1097/jnr.0000000000000063.
Cheng TA, Williams P The design and development of a screening questionnaire (CHQ) for use in community studies of mental disorders in Taiwan. Psychol Med. 1986 May;16(2):415-22.
Han AR, Park SA, Ahn BE Reduced stress and improved physical functional ability in elderly with mental health problems following a horticultural therapy program. Complement Ther Med. 2018 Jun;38:19-23. doi: 10.1016/j.ctim.2018.03.011. Epub 2018 Mar 28.
Heinrich LM, Gullone E The clinical significance of loneliness: a literature review. Clin Psychol Rev. 2006 Oct;26(6):695-718. Epub 2006 Jun 19. Review.
Söderback I, Söderström M, Schälander E Horticultural therapy: the 'healing garden'and gardening in rehabilitation measures at Danderyd Hospital Rehabilitation Clinic, Sweden. Pediatr Rehabil. 2004 Oct-Dec;7(4):245-60. Review.
Stern C, Konno R Physical Leisure Activities and their Role in Preventing Dementia: A Systematic Review. JBI Libr Syst Rev. 2009;7(8):260-308.
Yao YF, Chen KM Effects of horticulture therapy on nursing home older adults in southern Taiwan. Qual Life Res. 2017 Apr;26(4):1007-1014. doi: 10.1007/s11136-016-1425-0. Epub 2016 Oct 1.
The Effectiveness of 3DVR Horticultural Therapy on Older Adults' Physical and Mental Health
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
